Open Access. Powered by Scholars. Published by Universities.®

Translational Medical Research Commons

Open Access. Powered by Scholars. Published by Universities.®

Himmelfarb Health Sciences Library, The George Washington University

Doctor of Philosophy in Translational Health Sciences Dissertations

Series

Cotesting

Articles 1 - 1 of 1

Full-Text Articles in Translational Medical Research

Evaluating The Uptake Of Cotesting And Guideline Adherent Cervical Cancer Screening And Reported Barriers To Guideline Adherence In Academic And Community Practice Settings: A Mixed Methods Study, Shahnaz Khan Dec 2022

Evaluating The Uptake Of Cotesting And Guideline Adherent Cervical Cancer Screening And Reported Barriers To Guideline Adherence In Academic And Community Practice Settings: A Mixed Methods Study, Shahnaz Khan

Doctor of Philosophy in Translational Health Sciences Dissertations

Background: Clinical practice screening guidelines recommend cotesting, a test that combines DNA Human Papillomavirus (HPV) testing with cervical cytology (also known as Pap testing) every 5-years, as a highly effective and preferred method for cervical cancer prevention among average-risk women aged 30-65. Up to date empirical data on the current uptake of this evidence-based intervention is sparse and does not allow for a complete understanding of the actual use of cotesting at the extended screening interval in practice among patients and providers in different types of practice settings. The 2012 national cervical cancer screening guidelines have further expanded in 2018 …